Back to Search
Start Over
Benazepril: a new ACE inhibitor.
- Source :
-
ANNA journal [ANNA J] 1993 Apr; Vol. 20 (2), pp. 187-8. - Publication Year :
- 1993
-
Abstract
- Benazepril (Lotensin) is an ACE inhibitor that can be safely used in renal and liver disease. Statistical analysis of both single and repeated 10 mg oral doses shows no significant difference in action between young patients and those over 55. All ACE inhibitor drugs are in a homogenous class. One advantage that benazepril has over the others is convenience. It can be taken any time of day, with or without food, and most often is only needed once a day. This is important to our patients who are on multiple medication regimens. There are no clinically important pharmacologic interactions with digoxin, warfarin, naproxen, cimetidine, hydrochorothiazide, furosemide, propranolol, atenolol, or chlorthalidone.
- Subjects :
- Adult
Angiotensin-Converting Enzyme Inhibitors economics
Angiotensin-Converting Enzyme Inhibitors pharmacology
Benzazepines economics
Benzazepines pharmacology
Drug Costs
Humans
Kidney Failure, Chronic nursing
Middle Aged
Renal Dialysis
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Benzazepines therapeutic use
Kidney Failure, Chronic drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 8750-0779
- Volume :
- 20
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- ANNA journal
- Publication Type :
- Academic Journal
- Accession number :
- 8512378